Japan · Delayed Price · Currency is JPY Immuno-Biological Laboratories Company Description
Immuno-Biological Laboratories Co., Ltd. engages in the research, development, manufacturing, and supply of various immunological research reagents internationally.
The company offers ELILSA, an assay kit to quantitatively measure targeted substances; and supports research services on Alzheimer’s disease, metabolic syndrome, and cancer, as well as customized services for production of customized antibodies and development of ELISA test kits, antibodies, synthetic peptides, cell culture-related reagents, and contract services such as antibody preparation, purification and labeling, protein production by cell culture, and development of antibody-based measurement systems.
It also provides LipoSEARCH, a customized service for profiling and analyzing lipoprotein through gel-filtration, a high-performance liquid chromatography method that can profile various clinical samples, such as tiny plasma or serum samples from both small animals and human beings for a broad range of research fields including lipid metabolism, development of drugs for life-style related diseases, development of functional supplemental foods, and clinical studies.
In addition, the company offers LipoTEST, a support tool for diagnostic and health checks at animal clinics; and customized biomarker testing services for lifestyle-related diseases.
Further, it operates a protein production business using transgenic silkworms for manufacturing of antibodies for research reagents and diagnostic products; human collagen for cosmetic materials; development of proteins for use in drugs; and other protein production.
The company was incorporated in 1982 and is headquartered in Fujioka, Japan.
| Country | Japan |
| Founded | 1982 |
| Industry | Biotechnology |
| Sector | Healthcare |
| Employees | 54 |
| CEO | Tsutomu Seito |
Contact Details
Address: Fujioka Laboratory Fujioka, 375-0005 Japan | |
| Phone | 81 2 7422 2889 |
| Website | ibl-japan.co.jp |
Stock Details
| Ticker Symbol | 4570 |
| Exchange | Tokyo Stock Exchange |
| Stock Type | Common Stock |
| Fiscal Year | April - March |
| Reporting Currency | JPY |
| ISIN Number | JP3921300004 |
| SIC Code | 2834 |
Key Executives
| Name | Position |
|---|---|
| Tsutomu Seito | Chief Executive Officer |
| Masato Nakagawa | Chief Operating Officer |